tirzepatide legal team in kentucky law office Louisville Employment Attorneys Ozempic Lawyer in Kentucky |

The SUMMIT trial took this further with tirzepatide, showing a 38% reduction in the composite of cardiovascular death or worsening heart failure (HR 0.62) in patients with HFpEF and obesity, along with a clinically meaningful 6.9-point improvement in KCCQ scores

FAQ What are GLP-1 peptides

Eat Weight Disord-Stud

Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)

doi: 10.3803/EnM.2014.29.4.536 70 KrnerMStckliMWaserBReubiJC